Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001121

Drug Information
NameBenztropine    
SynonymsBenzatropine; Cogentinol; BSPBio_001912; Pms Benztropine; AC1L9B14; CHEMBL32104; 3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane; NCGC00162087-02; 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo- (9CI); (5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; C06846; 1-alpha-H,5-alpha-H-Tropane, 3-alpha-(diphenylmethoxy)-; (3-endo)-3-[(diphenylmethyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane; AC1Q57W9; Cogentine; Benzatropinum; 92498-18-5; KBio3_001412; Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether; Benzatropine mesilate; AR-1A1320; NCGC00159471-02; NK 02; L000767; 1alphaH,5alphaH-tropane, 3alpha-(diphenylmethoxy)-; KBioGR_000682; AC1Q3ZKJ; CHEBI:3048; Apo-Benztropine; CID441353; Spectrum_000078; STK931885; Benztropinum; Lopac0_000194; Benzatropina [INN-Spanish]; (1R,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; Spectrum5_000884; 3alpha-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; KBio2_005614; NCGC00162087-01; AR-1E7616; AC1L1NEG; 3endo-benzhydryloxytropane; KBioSS_000478; SPBio_000092; Spectrum3_000316; NCGC00162087-03; Spectrum4_000251; benztropine; CID2344; CID1201549; DivK1c_000523; KBio1_000523; IDI1_000523; Benzatropine [INN]; 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-; KBio2_003046; Benzatropina; DB00245; Spectrum2_000106; NCIOpen2_008292; NCI60_003960; Cobrentin; C21H25NO; CID6832; AC1Q57ZM; 86-13-5; 3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; HSDB 3014; Tropine benzohydryl ether; Benzatropinum [INN-Latin]; Akitan; KBio2_000478; (1r,5r)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane; 3alpha-(diphenylmethoxy)tropane; Benzatropine [INN:BAN]; AC1L1DGX; Benzatropine (INN); AC1Q3XL3; D07511; Oprea1_754774; NINDS_000523; 8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, endo-; MolPort-001-792-508; UNII-1NHL2J4X8K; 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane; KST-1A8933; (3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane; LS-157780    
Trade NameCogentin    
IndicationParkinson's diseaseApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntiparkinson Agents    
PubChem Compound IDCID 441353.    
PubChem Substance IDSID 36885211.    
SuperDrug ATC IDN04AC01;    
SuperDrug CAS ID000086135;    
TargetMuscarinic acetylcholine receptor M1Antagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040103 To Reference
Ref 2Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. Int J Pharm. 2008 Jun 5;357(1-2):55-60. Epub 2008 Jan 20. To Reference
Ref 3Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. Pharmacol Biochem Behav. 2007 Oct;87(4):400-4. Epub 2007 Jun 2. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543